NO992781D0 - FremgangsmÕte for kopling av ligander til en fast fase i sur oppl°sning og anionisk overflateaktivt stoff - Google Patents

FremgangsmÕte for kopling av ligander til en fast fase i sur oppl°sning og anionisk overflateaktivt stoff

Info

Publication number
NO992781D0
NO992781D0 NO992781A NO992781A NO992781D0 NO 992781 D0 NO992781 D0 NO 992781D0 NO 992781 A NO992781 A NO 992781A NO 992781 A NO992781 A NO 992781A NO 992781 D0 NO992781 D0 NO 992781D0
Authority
NO
Norway
Prior art keywords
solid phase
anionic surfactant
acid solution
coupling
antibody
Prior art date
Application number
NO992781A
Other languages
English (en)
Other versions
NO320586B1 (no
NO992781L (no
Inventor
Juhani Luotola
Martti Malassu
Original Assignee
Orion Yhtymo Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymo Oyj filed Critical Orion Yhtymo Oyj
Publication of NO992781D0 publication Critical patent/NO992781D0/no
Publication of NO992781L publication Critical patent/NO992781L/no
Publication of NO320586B1 publication Critical patent/NO320586B1/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19992781A 1996-12-17 1999-06-08 Fremgangsmate for kovalent kopling av et antistoffmolekyl, et fragment derav eller et antigenmolekyl til en fast fase. NO320586B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI965066A FI101543B (fi) 1996-12-17 1996-12-17 Biomolekyylien kytkeminen kiintofaasiin
PCT/FI1997/000774 WO1998027429A1 (en) 1996-12-17 1997-12-10 Method of coupling ligands to a solid phase in acidic solution and anionic surfactant

Publications (3)

Publication Number Publication Date
NO992781D0 true NO992781D0 (no) 1999-06-08
NO992781L NO992781L (no) 1999-06-08
NO320586B1 NO320586B1 (no) 2005-12-27

Family

ID=8547295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992781A NO320586B1 (no) 1996-12-17 1999-06-08 Fremgangsmate for kovalent kopling av et antistoffmolekyl, et fragment derav eller et antigenmolekyl til en fast fase.

Country Status (13)

Country Link
US (1) US6358753B1 (no)
EP (1) EP0946871B1 (no)
JP (1) JP3845118B2 (no)
AT (1) ATE221199T1 (no)
AU (1) AU732232B2 (no)
CA (1) CA2274956C (no)
DE (1) DE69714291T2 (no)
DK (1) DK0946871T3 (no)
ES (1) ES2179376T3 (no)
FI (1) FI101543B (no)
IL (1) IL130459A (no)
NO (1) NO320586B1 (no)
WO (1) WO1998027429A1 (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703018A (en) 1985-02-20 1987-10-27 E. I. Du Pont De Nemours And Company High refractive index haloalkyl-functional shell-core polymers and their use in light scattering immunoassays
EP0257758B1 (en) 1986-08-07 1993-03-10 Minnesota Mining And Manufacturing Company Stable biologically active fluorochemical emulsions
US5585278A (en) 1994-10-27 1996-12-17 Bayer Corporation Method for coupling antibody to novel latex substrate and its use in immunoassay

Also Published As

Publication number Publication date
FI101543B1 (fi) 1998-07-15
JP2001509887A (ja) 2001-07-24
NO320586B1 (no) 2005-12-27
DE69714291D1 (de) 2002-08-29
JP3845118B2 (ja) 2006-11-15
EP0946871A1 (en) 1999-10-06
WO1998027429A1 (en) 1998-06-25
AU732232B2 (en) 2001-04-12
ATE221199T1 (de) 2002-08-15
CA2274956C (en) 2007-07-03
CA2274956A1 (en) 1998-06-25
DK0946871T3 (da) 2002-11-04
DE69714291T2 (de) 2003-03-20
FI101543B (fi) 1998-07-15
IL130459A0 (en) 2000-06-01
ES2179376T3 (es) 2003-01-16
NO992781L (no) 1999-06-08
EP0946871B1 (en) 2002-07-24
IL130459A (en) 2002-07-25
US6358753B1 (en) 2002-03-19
FI965066A0 (fi) 1996-12-17
AU5224098A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE374248T1 (de) Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
DK1226177T3 (da) Antistofsammensætninger mod anti-prostata stamcelle-antigen (PSCA) og anvendelser deraf
NO166618C (no) Fremgangsmaate for fremstilling av immunoenzymatiske konjugater som ved kovalent binding binder sammen et enzym og et antistoff.
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
Meyer et al. Orthogonal protein decoration of DNA nanostructures
DE69433341D1 (de) Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
AU2738900A (en) Methods for enhancing binding interactions between members of specific binding pairs
EP0889056A3 (en) Process for making a cyclodextrin
TR199902326T2 (xx) Anti-hiperkolesterinemikler olarak ikameli piridinler ve bifeniller.
NO995999L (no) Fremgangsmåte til å rense melkesyre
ATE297400T1 (de) Verfahren zur herstellung organischer boronsäurederivate mit hilfe von diboronsäure
DK0870014T3 (da) Katalytiske antistoffer mod aldolase
Turner The use of alkaline-phosphatase-conjugated second antibody for the visualization of electrophoretically separated proteins recognized by monoclonal antibodies
EP0802411A3 (en) Measurement method and kit for hemoglobin A1c
ATE429484T1 (de) Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
Smith [17] Reversible blocking at arginine by cyclohexanedione
ATE285790T1 (de) Herstellungsverfahren von festphasekonjugateimpfstoffen
NO992781L (no) FremgangsmÕte for kopling av ligander til en fast fase i sur oppl°sning og anionisk overflateaktivt stoff
Orii et al. Molecular architecture of cytochrome oxidase and its transition on treatment with alkali or sodium dodecyl sulfate
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
ATE250567T1 (de) Verfahren zur entwässerung organischer flüssigkeiten
DE3851221D1 (de) Nichttrennender festphasen-enzymtest.
AR001889A1 (es) Un procedimiento para la preparación de 1-acil-4-(3-picolil)-2-ter-butilcarboxamidopiperazina
DE60138130D1 (de) Proteomanalyse verfahren zum drogen vergleich
ATE28861T1 (de) Chloramphenicol-derivate, zwischenprodukt und verfahren dazu.

Legal Events

Date Code Title Description
MK1K Patent expired